{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:06:22Z","timestamp":1784646382386,"version":"3.55.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Unexplained left ventricular hypertrophy (LVH) represents a diagnostic challenge, as phenotypic overlap may exist between sarcomeric hypertrophic cardiomyopathy (HCM) and infiltrative cardiomyopathies such as transthyretin amyloid cardiomyopathy (ATTR-CM). Multimodality imaging and genetic testing are crucial when standard findings are discordant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 78-year-old woman presented with exertional dyspnoea (NYHA class II) and asymmetric septal hypertrophy without secondary causes. Transthoracic echocardiography showed preserved left ventricular ejection fraction with reduced basal longitudinal strain and relative apical sparing. Cardiac magnetic resonance demonstrated elevated native T1 values (1240\u20131270\u2005ms), mildly increased T2 values, and basal ring-like late gadolinium enhancement. Bone scintigraphy revealed Perugini grade 3 myocardial uptake, consistent with ATTR-CM. Monoclonal gammopathy was excluded. Genetic testing identified a pathogenic transthyretin mutation (TTR p.Ile88Leu) and a concomitant likely pathogenic sarcomeric MYH7 variant (p.Gly733Arg). Neurological assessment was unremarkable. The overall phenotype was dominated by amyloid infiltration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Following multidisciplinary evaluation, the patient was started on tafamidis 61\u2005mg once daily. Cascade genetic and clinical screening was recommended for first-degree relatives.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytag515","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:57:57Z","timestamp":1783684677000},"source":"Crossref","is-referenced-by-count":0,"title":["Coexistence of hereditary transthyretin amyloid cardiomyopathy and sarcomeric hypertrophic cardiomyopathy: a multimodality imaging and genetic case report"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2909-3928","authenticated-orcid":false,"given":"Francesco","family":"Negri","sequence":"first","affiliation":[{"name":"Cardiothoracic Department, University Hospital \u2018Santa Maria della Misericordia\u2019, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) , Piazzale Santa Maria della Misericordia 15, 33100 Udine ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Driussi","sequence":"additional","affiliation":[{"name":"Cardiothoracic Department, University Hospital \u2018Santa Maria della Misericordia\u2019, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) , Piazzale Santa Maria della Misericordia 15, 33100 Udine ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Puppato","sequence":"additional","affiliation":[{"name":"Radiology Department, University Hospital \u2018Santa Maria della Misericordia\u2019, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) , Piazzale Santa Maria della Misericordia 15, 33100 Udine ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3817-5929","authenticated-orcid":false,"given":"Lorenzo","family":"Zuliani","sequence":"additional","affiliation":[{"name":"Radiology Department, University Hospital \u2018Santa Maria della Misericordia\u2019, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) , Piazzale Santa Maria della Misericordia 15, 33100 Udine ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0245","authenticated-orcid":false,"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[{"name":"Cardiothoracic Department, University Hospital \u2018Santa Maria della Misericordia\u2019, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) , Piazzale Santa Maria della Misericordia 15, 33100 Udine ,","place":["Italy"]},{"name":"Department of Medicine, University of Udine , 33100 Udine ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2026072110563257800_ytag515-B1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2026072110563257800_ytag515-B2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2026072110563257800_ytag515-B3","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"2026072110563257800_ytag515-B4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026072110563257800_ytag515-B5","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain for cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"2026072110563257800_ytag515-B6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"2026072110563257800_ytag515-B7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026072110563257800_ytag515-B8","first-page":"512","article-title":"Role of 99mTc-DPD scintigraphy in hereditary transthyretin amyloidosis","volume":"58","author":"Rapezzi","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026072110563257800_ytag515-B9","first-page":"735","article-title":"Defining the genetic architecture of hypertrophic cardiomyopathy","volume":"49","author":"Walsh","year":"2017","journal-title":"Nat Genet"},{"key":"2026072110563257800_ytag515-B10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacc.2025.09.004","article-title":"Transthyretin cardiac amyloidosis evaluation and management: 2025 ACC concise clinical guidance","volume":"87","author":"Kittleson","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026072110563257800_ytag515-B11","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2024.03.429","article-title":"SGLT2 inhibitor therapy in patients with transthyretin amyloid cardiomyopathy","volume":"83","author":"Porcari","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026072110563257800_ytag515-B12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/13506129.2021.1917357","article-title":"Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation","volume":"28","author":"Pastorelli","year":"2021","journal-title":"Amyloid"},{"key":"2026072110563257800_ytag515-B13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jacc.2025.11.028","article-title":"Beta-blocker (bisoprolol) vs calcium-channel blocker (verapamil) in nonobstructive hypertrophic cardiomyopathy: a randomized triple-crossover physiologic trial","volume":"87","author":"Bjerregaard","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026072110563257800_ytag515-B14","doi-asserted-by":"crossref","first-page":"102236","DOI":"10.1016\/j.jaccas.2024.102236","article-title":"ATTR gene variants in HCM","volume":"29","author":"Kanelidis","year":"2024","journal-title":"JACC Case Rep"},{"key":"2026072110563257800_ytag515-B15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/joim.13200","article-title":"Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype","volume":"289","author":"Cappelli","year":"2021","journal-title":"J Intern Med"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytag515\/68756639\/ytag515.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/7\/ytag515\/68756639\/ytag515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/7\/ytag515\/68756639\/ytag515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:56:40Z","timestamp":1784645800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytag515\/8732196"}},"subtitle":[],"editor":[{"given":"Giacomo Tini","family":"Melato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Yanjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Ana","family":"Devesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Michael","family":"Chetrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytag515","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"ytag515"}}